Filing Details

Accession Number:
0001610717-24-000427
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-08-15 16:48:18
Reporting Period:
2024-08-13
Accepted Time:
2024-08-15 16:48:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1628171 Revolution Medicines Inc. RVMD () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1462808 Michael Stephen Kelsey C/O Revolution Medicines, Inc.
700 Saginaw Drive
Redwood City CA 94063
See Remarks No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-08-13 16,667 $4.09 285,740 No 4 M Direct
Common Stock Disposition 2024-08-13 16,667 $42.98 269,073 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2024-08-13 16,667 $0.00 16,667 $4.09
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
56,665 2023-03-13 2029-03-12 No 4 M Direct
Footnotes
  1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024.
  2. Includes 95,476 restricted stock units.
  3. The transaction was executed in multiple trades in prices ranging from $42.76 to $43.42, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.